ENDRA Life Sciences Statistics Share Statistics ENDRA Life Sciences has 752.75K
shares outstanding. The number of shares has increased by 40.2%
in one year.
Shares Outstanding 752.75K Shares Change (YoY) 40.2% Shares Change (QoQ) 1.95% Owned by Institutions (%) 0.01% Shares Floating 752.66K Failed to Deliver (FTD) Shares 5,548 FTD / Avg. Volume 0.34%
Short Selling Information The latest short interest is 105.56K, so 14.02% of the outstanding
shares have been sold short.
Short Interest 105.56K Short % of Shares Out 14.02% Short % of Float 14.02% Short Ratio (days to cover) 2.51
Valuation Ratios The PE ratio is -0.61 and the forward
PE ratio is -0.64.
ENDRA Life Sciences's PEG ratio is
-0.01.
PE Ratio -0.61 Forward PE -0.64 PS Ratio 0 Forward PS 14.4 PB Ratio 2.74 P/FCF Ratio -0.95 PEG Ratio -0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for ENDRA Life Sciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.67,
with a Debt / Equity ratio of 0.23.
Current Ratio 5.67 Quick Ratio 5.67 Debt / Equity 0.23 Debt / EBITDA -0.05 Debt / FCF -0.08 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-548K Employee Count 21 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -20.25% in the
last 52 weeks. The beta is -0.09, so ENDRA Life Sciences's
price volatility has been lower than the market average.
Beta -0.09 52-Week Price Change -20.25% 50-Day Moving Average 4.8 200-Day Moving Average 4.7 Relative Strength Index (RSI) 71.33 Average Volume (20 Days) 1,615,109
Income Statement
Revenue n/a Gross Profit -206.17K Operating Income -18.14M Net Income -11.51M EBITDA -11.3M EBIT -11.51M Earnings Per Share (EPS) -10.25
Full Income Statement Balance Sheet The company has 3.23M in cash and 584.42K in
debt, giving a net cash position of 2.65M.
Cash & Cash Equivalents 3.23M Total Debt 584.42K Net Cash 2.65M Retained Earnings -103.44M Total Assets 2.81M Working Capital 1.28M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -7.4M
and capital expenditures -16K, giving a free cash flow of -7.42M.
Operating Cash Flow -7.4M Capital Expenditures -16K Free Cash Flow -7.42M FCF Per Share -6.61
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields NDRA does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for NDRA is $38,
which is 560.9% higher than the current price. The consensus rating is "Buy".
Price Target $38 Price Target Difference 560.9% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Nov 7, 2024. It was a
backward
split with a ratio of 1:35.
Last Split Date Nov 7, 2024 Split Type backward Split Ratio 1:35
Scores Altman Z-Score -60.08 Piotroski F-Score 2
